| Mohammad Yousuf, MD | |
|
227 Metro Dr, Jefferson City, MO 65109-1134 | |
| (888) 403-1071 | |
| Not Available |
| Full Name | Mohammad Yousuf |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 227 Metro Dr, Jefferson City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942571476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2015031215 (Missouri) | Primary |
| Entity Name | State Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164477873 PECOS PAC ID: 1456254226 Enrollment ID: O20040129000481 |
News Archive
Thirty-three states are trying to block the mandate on individual American citizens to purchase health insurance, "as a growing roster of mostly Republican officials have mounted legal and legislative challenges" to this requirement. "This Friday, seven more states will formally join a lawsuit originally filed by Florida and 12 other states in late March.
AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates.
Today a group of national and California-based partners hosted the California Bioscience Business Roundtable (BBR) event at the Quadrus Conference Center in Menlo Park. The event also featured Sam Youngman, the White Correspondent for The Hill newspaper, who provided a reporter's front row perspective on the unfolding health reform debate in Washington, D.C.
Vanda Pharmaceuticals Inc. today announced top-line results of the Phase IIb/III clinical study (MAGELLAN) in Major Depressive Disorder (MDD), investigating the efficacy and safety of tasimelteon as a monotherapy in the treatment of patients with MDD.
Death panels. Government-sponsored euthanasia. Pulling the plug on grandma. Those were just some of the blatantly false terms conservatives threw around last year to scare Congress into stripping a provision out of the health-reform bill that would have allowed Medicare to reimburse doctors for providing voluntary, end-of-life counseling to their patients. The scare tactics worked (1/2).
› Verified 3 days ago
| Entity Name | Compass Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285619494 PECOS PAC ID: 1951206754 Enrollment ID: O20040408000955 |
News Archive
Thirty-three states are trying to block the mandate on individual American citizens to purchase health insurance, "as a growing roster of mostly Republican officials have mounted legal and legislative challenges" to this requirement. "This Friday, seven more states will formally join a lawsuit originally filed by Florida and 12 other states in late March.
AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates.
Today a group of national and California-based partners hosted the California Bioscience Business Roundtable (BBR) event at the Quadrus Conference Center in Menlo Park. The event also featured Sam Youngman, the White Correspondent for The Hill newspaper, who provided a reporter's front row perspective on the unfolding health reform debate in Washington, D.C.
Vanda Pharmaceuticals Inc. today announced top-line results of the Phase IIb/III clinical study (MAGELLAN) in Major Depressive Disorder (MDD), investigating the efficacy and safety of tasimelteon as a monotherapy in the treatment of patients with MDD.
Death panels. Government-sponsored euthanasia. Pulling the plug on grandma. Those were just some of the blatantly false terms conservatives threw around last year to scare Congress into stripping a provision out of the health-reform bill that would have allowed Medicare to reimburse doctors for providing voluntary, end-of-life counseling to their patients. The scare tactics worked (1/2).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Yousuf, MD 1800 Community, Clinton, MO 64735-8804 Ph: (660) 890-8131 | Mohammad Yousuf, MD 227 Metro Dr, Jefferson City, MO 65109-1134 Ph: (888) 403-1071 |
News Archive
Thirty-three states are trying to block the mandate on individual American citizens to purchase health insurance, "as a growing roster of mostly Republican officials have mounted legal and legislative challenges" to this requirement. "This Friday, seven more states will formally join a lawsuit originally filed by Florida and 12 other states in late March.
AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates.
Today a group of national and California-based partners hosted the California Bioscience Business Roundtable (BBR) event at the Quadrus Conference Center in Menlo Park. The event also featured Sam Youngman, the White Correspondent for The Hill newspaper, who provided a reporter's front row perspective on the unfolding health reform debate in Washington, D.C.
Vanda Pharmaceuticals Inc. today announced top-line results of the Phase IIb/III clinical study (MAGELLAN) in Major Depressive Disorder (MDD), investigating the efficacy and safety of tasimelteon as a monotherapy in the treatment of patients with MDD.
Death panels. Government-sponsored euthanasia. Pulling the plug on grandma. Those were just some of the blatantly false terms conservatives threw around last year to scare Congress into stripping a provision out of the health-reform bill that would have allowed Medicare to reimburse doctors for providing voluntary, end-of-life counseling to their patients. The scare tactics worked (1/2).
› Verified 3 days ago
Elbert Stinson Tillerson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St., Jefferson City, MO 65102 Phone: 573-635-7651 Fax: 573-659-4515 | |
Dr. Colleen Teresa Loehr, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2013 Williams St, Jefferson City, MO 65109 Phone: 573-636-8108 | |
Dr. John W Clemens, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2701 W Edgewood Dr, Suite 101, Jefferson City, MO 65109 Phone: 573-634-5303 Fax: 573-761-6888 | |
Jack E Matteson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1026 Northeast Dr, Ste E, Jefferson City, MO 65109 Phone: 573-635-3850 Fax: 573-635-1558 | |
Krishna Kanth R Mettu, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-761-4351 | |
John C Lyskowski, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2701 W Edgewood Dr, Suite 101, Jefferson City, MO 65109 Phone: 573-634-5303 Fax: 573-761-6888 | |
Emma Seli Afua Hayford, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 141 Scott Station Rd, Jefferson City, MO 65109 Phone: 609-481-0124 |